Granules India recalls over 2.3 cr ranitidine tablets from US market Farhat Nasim13 Jan 2020 6:29 AMNew Delhi: Drug firm Granules India is recalling over 2.3 crore ranitidine tablets, used to treat ulcers of the stomach and intestines, from the US...
Cipla launches skin treatment Daptomycin Injection in US Medical Dialogues Bureau27 Sept 2019 8:23 AMDrug firm Cipla on Wednesday said it has launched Daptomycin Injection, used for treating complicated skin infections, in the US market. Daptomycin...
Cadila Healthcare gets OAI letter from USFDA for Moraiya facility Medical Dialogues Bureau8 Aug 2019 4:30 AMThe company has received a letter from the USFDA classifying the inspection conducted at its Moraiya facility from April 22 to May 3 as OAI, Cadila...
USFDA inspected Goa facility, no observations issued: Indoco Remedies Farhat Nasim30 March 2019 6:22 AMThe US Food and Drug Administration (USFDA) has cleared the Goa-based sterile manufacturing facility of Indoco Remedies for finished dosages.New...
Indoco Remedies gets two minor observations from USFDA for Goa plants Medical Dialogues Bureau25 Nov 2018 3:37 AMMumbai: Drug firm Indoco Remedies on Thursday said it has received two minor observations from the US health regulator for its Goa-based two plants....
